Schwarzová Lucie
Vnitr Lek. 2016 Fall;62(11):877-881.
The review focuses on the molecular background of an inborn error of lipid metabolism -familial hypercholesterolemia. FH describes a group of genetic defects resulting in severe elevations of blood cholesterol levels and increased risk of premature coronary heart disease. Most cases are due to the mutations decreasing and/or destroying the function of the LDL receptor (85-90 % of cases), smaller portion of cases is caused by defects in the gene encoding the ligand for LDL receptor - apolipoprotein B-100 (5-10 %). Less than 5 % of cases has gain-of-function station of the PCSK9 gene that increases the rate of degradation of the LDL receptor molecules. Autosomal recessive form of the disease, caused by the mutations in LDLR adaptor protein 1 gene, is extremely rare.Key words: APOB - familial hypercholesterolemia - LDLR - LDLRAP1 - PCSK9.
本综述聚焦于一种脂质代谢先天性缺陷——家族性高胆固醇血症的分子背景。家族性高胆固醇血症描述了一组导致血液胆固醇水平严重升高以及早发性冠心病风险增加的基因缺陷。大多数病例是由于降低和/或破坏低密度脂蛋白受体功能的突变(85 - 90%的病例),较少部分病例是由编码低密度脂蛋白受体配体——载脂蛋白B - 100的基因缺陷引起的(5 - 10%)。不到5%的病例具有前蛋白转化酶枯草溶菌素9(PCSK9)基因功能获得性突变,该突变会增加低密度脂蛋白受体分子的降解速率。由低密度脂蛋白受体衔接蛋白1基因的突变引起的常染色体隐性疾病形式极为罕见。关键词:载脂蛋白B - 家族性高胆固醇血症 - 低密度脂蛋白受体 - 低密度脂蛋白受体衔接蛋白1 - 前蛋白转化酶枯草溶菌素9 。